PAOG To Expand Revenue Base Introducing New CBD Nutraceuticals Targeting $3.8 Billion Market
Sandusky, Ohio--(Newsfile Corp. - February 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today revealed plans to expand its nutraceutical product reach. The company plans to produce nutraceuticals for additional applications beyond the current focus on care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD).Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive...
2021-02-04 1:14 PM EST
PAOG Confirms $300,000 Sales Agreement with Cannabis Cultivation Subsidiary
Sandusky, Ohio--(Newsfile Corp. - February 3, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a $300,000 sales agreement executed by the Company's cannabis cultivation subsidiary. PAOG anticipates approximately $50,000 in revenue per quarter for six quarters starting with an estimated $50,000 in revenue expected to be reported for Q4 2020.Last summer, PAOG acquired a cannabis cultivation business from Puration, Inc. (OTC Pink: PURA). The acquisition was made in conjunction with...
2021-02-03 2:19 PM EST
PAOG Confirms CBD Nutraceutical Development and Distribution Partners
Sandusky, Ohio--(Newsfile Corp. - February 2, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed its plans to develop and distribute cannabis nutraceuticals with Alkame Holdings, Inc. (OTC Pink: ALKM) and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) as partners.PAOG recently engaged with the Puerto Rico Consortium for Clinical Investigation (PRCCI) to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical product to provide care for those...
2021-02-02 1:21 PM EST
PAOG To Distribute CBD Nutraceuticals Through USMJ Ecommerce Site
Sandusky, Ohio--(Newsfile Corp. - January 27, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced moving forward with its initiative to produce cannabis nutraceuticals. PAOG added that the nutraceuticals, in addition to other distribution channels, will be available through the North American Cannabis, Inc. (OTC Pink: USMJ) ecommerce site www.usjm.com.
2021-01-27 12:59 PM EST
PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook
Sandusky, Ohio--(Newsfile Corp. - January 14, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today published a management outlook for 2021 on the company's strategy to develop and monetize the cannabis assets acquired last year. The strategic outlook is included in its entirety below:PAOG 2021 Cannabis Biopharmaceutical Strategic OutlookPAOG is a longtime participant in the cannabis sector working on initiatives to introduce cannabis treatments as alternatives to traditional pharmaceuticals,...
2021-01-14 9:33 AM EST
PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow
Sandusky, Ohio--(Newsfile Corp. - January 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced the upcoming update covering the company's 2021 cannabis pharmaceutical and nutraceutical development outlook scheduled for tomorrow, Thursday Jan 14th, 2021, will include an update on the planned PAOG stock dividend to shareholders of Puration, Inc. (OTC Pink: PURA) in conjunction with PAOG's acquisition of hemp cultivation business from PURA.In 2020, PAOG acquired a hemp cultivation...
2021-01-13 10:16 AM EST
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Sandusky, Ohio--(Newsfile Corp. - January 12, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed an update covering the company's 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021.In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disease (COPD) derived from...
2021-01-12 11:51 AM EST
PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Sandusky, Ohio--(Newsfile Corp. - January 11, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced an update covering the company's 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disease (COPD) derived...
2021-01-11 11:31 AM EST
PAOG Confirms Q4 2020 Revenue from Cannabis Asset Acquisition
Sandusky, Ohio--(Newsfile Corp. - January 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed that the Company expects to realize and report in Q4 2020 the first revenue from assets acquired in the course of 2020.In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method - U.S. Patent No....
2021-01-08 11:44 AM EST
PAOG Takes Major CBD Pharmaceutical Development Step Forward
Sandusky, Ohio--(Newsfile Corp. - January 5, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced a major step forward in the development of a CBD pharmaceutical product.PAOG today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough, Massachusetts. PAOG has engaged Veristat to assist in advancing PAOG with its proprietary Cannabidiol (CBD) extract for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) toward initiating an...
2021-01-05 11:18 AM EST
PAOG Expects to Report First Post Acquisition Revenue in Q4 2020
Sandusky, Ohio--(Newsfile Corp. - December 22, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced that the company expects to realize and report in Q3 2020 the first revenue from assets acquired in the course of 2020.In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY) RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method - U.S. Patent No....
2020-12-22 12:16 PM EST
PAOG Develops CBD Nutraceutical for $12.7 Billion from Patented Extract Process
Sandusky, Ohio--(Newsfile Corp. - December 18, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to generate its first revenue next year in 2021 from its Cannabidiol (CBD) extraction technology, RespRx, acquired in July of this year, 2020.Yesterday, PAOG announced an engagement with the Puerto Rico Consortium for Clinical Investigation (PRCCI) to assist PAOG with developing its proprietary CBD extract into a nutraceutical product to provide care for those...
2020-12-18 3:09 PM EST
PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution
Sandusky, Ohio--(Newsfile Corp. - December 17, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an engagement with the Puerto Rico Consortium for Clinical Investigation to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical product to provide care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD). On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY) RespRx is a cannabis...
2020-12-17 12:19 PM EST
PAOG CEO Discusses 2020 Progress And PURA Dividend On MoneyTV
Sandusky, Ohio--(Newsfile Corp. - November 25, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an interview of CEO, Jim DiPrima on MoneyTV where Mr. DiPrima discusses the Company's progress in 2020 to include the latest updates on PAOG's coming one for one dividend of PAOG stock to Puration, Inc. (OTC Pink: PURA) shareholders in conjunction with PAOG's recent acquisition of PURA's cannabis cultivation business.Cannot view this video?...
2020-11-25 1:09 PM EST
PAOG Publishes First Financial Report Following Two Strategic Acquisitions
Dallas, Texas--(Newsfile Corp. - November 17, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced publishing its Q3 2020 report with OTC Markets. This is the first report since making two strategic acquisitions in the course of the third quarter. PAOG transitioned its business direction in the previous quarter making the acquisition of a cannabis extraction technology called RespRx, developed for the treatment of Chronic Obstructive Pulmonary Disease (COPD), in addition to acquiring a...
2020-11-17 9:03 AM EST
PAOG Building CBD Pharma Capacity in Partnership with PURA - Partnership Includes PAOG Stock Dividend to PURA Shareholders
Sandusky, Ohio--(Newsfile Corp. - November 12, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a pharmaceutical and neurocritical extraction partnership with Puration, Inc. (OTC Pink: PURA).PURA has acquired a 72-acre property in Farmersville, Texas as the foundation of an innovative, hemp processing plant. PURA is building partnerships to participate in the project to include a pharmaceutical and neurocritical extraction partnership with PAOG.PURA has also established a co-packing...
2020-11-12 10:54 AM EST
PAOG Advances Nutraceutical Development From Its Cannabis Pharmaceutical Research
Sandusky, Ohio--(Newsfile Corp. - October 29, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced adding a nutraceutical development pathway to its existing pharmaceutical cannabis drug development strategy. Last week, PAOG announced a master services agreement with a clinical research organization (CRO) in the U.S. to prepare PAOG for initiating an investigational New Drug application (IND) with the Food and Drug Administration (FDA). More details on the CRO contract are coming soon....
2020-10-29 1:16 PM EDT
PAOG Signs Clinical Research Organization (CRO) to Advance Respiratory Cannabis Treatment Through Regulatory Approval
Sandusky, Ohio--(Newsfile Corp. - October 23, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced executing a master services agreement with a clinical research organization in the U.S. to prepare PAOG for initiating an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG signed the agreement yesterday, prior to the comprehensive corporate update scheduled for publication today and included in its entirety below.Corporate UpdateLess than 90 days...
2020-10-23 9:20 AM EDT
PAOG Advances FDA Application Process For Respiratory Cannabis Drug Treatment
Sandusky, Ohio--(Newsfile Corp. - October 20, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced that the company plans to release a new key update this Friday, October 23, 2020, on its progress to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG announced last week that it soon anticipates to enter into an agreement with a contract research organization (CRO) making a major breakthrough in advancing PAOG's RespRx treatment for...
2020-10-20 9:18 AM EDT
PAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp Awareness
Sandusky, Ohio--(Newsfile Corp. - October 16, 2020) - PAO Group, Inc. (OTC Pink: PAOG) and Puration, Inc. (OTC Pink: PURA) today announced a free hemp seed giveaway in conjunction with the recent partnership between the two companies where PAOG will be building a hemp cultivation facility on PURA's Farmersville, Texas property. HEMPTo view an enhance
2020-10-16 1:17 PM EDT